Dermatologic reactions: urticaria, rash, pruritus, erythema multiforme, toxic epidermal necrolysis and Stevens-Johnson Syndrome.
Gastrointestinal: nausea (2%), vomiting, diarrhea (1.8%), Pseudomembranous colitis, hepatitis, jaundice.
Haematology: increase eosinophils, agranulocytosis, thrombocytopenia, thrombocytosis positive direct Coombs' test.
Hepatic: increased transaminases, alkaline phosphatase and bilirubin.
Central Nervous System: seizures.
Electrolyte: decreased blood sodium level, increased blood potassium level and blood chloride level.
View ADR Monitoring Form